181 related articles for article (PubMed ID: 18483308)
21. Gefitinib circumvents hypoxia-induced drug resistance by the modulation of HIF-1alpha.
Rho JK; Choi YJ; Lee JK; Ryoo BY; Na II; Yang SH; Kim CH; Yoo YD; Lee JC
Oncol Rep; 2009 Mar; 21(3):801-7. PubMed ID: 19212642
[TBL] [Abstract][Full Text] [Related]
22. Overcoming cisplatin resistance of ovarian cancer cells by targeting HIF-1-regulated cancer metabolism.
Ai Z; Lu Y; Qiu S; Fan Z
Cancer Lett; 2016 Apr; 373(1):36-44. PubMed ID: 26801746
[TBL] [Abstract][Full Text] [Related]
23. Hypoxia-induced cytotoxic drug resistance in osteosarcoma is independent of HIF-1Alpha.
Adamski J; Price A; Dive C; Makin G
PLoS One; 2013; 8(6):e65304. PubMed ID: 23785417
[TBL] [Abstract][Full Text] [Related]
24. Up-regulation of survivin by AKT and hypoxia-inducible factor 1α contributes to cisplatin resistance in gastric cancer.
Sun XP; Dong X; Lin L; Jiang X; Wei Z; Zhai B; Sun B; Zhang Q; Wang X; Jiang H; Krissansen GW; Qiao H; Sun X
FEBS J; 2014 Jan; 281(1):115-28. PubMed ID: 24165223
[TBL] [Abstract][Full Text] [Related]
25. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
Chen MC; Lee CF; Huang WH; Chou TC
Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
[TBL] [Abstract][Full Text] [Related]
26. Bufalin suppresses hepatocellular carcinoma invasion and metastasis by targeting HIF-1α via the PI3K/AKT/mTOR pathway.
Wang H; Zhang C; Xu L; Zang K; Ning Z; Jiang F; Chi H; Zhu X; Meng Z
Oncotarget; 2016 Apr; 7(15):20193-208. PubMed ID: 26958938
[TBL] [Abstract][Full Text] [Related]
27. Hypoxia up-regulates hypoxia-inducible factor-1alpha transcription by involving phosphatidylinositol 3-kinase and nuclear factor kappaB in pulmonary artery smooth muscle cells.
Belaiba RS; Bonello S; Zähringer C; Schmidt S; Hess J; Kietzmann T; Görlach A
Mol Biol Cell; 2007 Dec; 18(12):4691-7. PubMed ID: 17898080
[TBL] [Abstract][Full Text] [Related]
28. Bortezomib represses HIF-1α protein expression and nuclear accumulation by inhibiting both PI3K/Akt/TOR and MAPK pathways in prostate cancer cells.
Befani CD; Vlachostergios PJ; Hatzidaki E; Patrikidou A; Bonanou S; Simos G; Papandreou CN; Liakos P
J Mol Med (Berl); 2012 Jan; 90(1):45-54. PubMed ID: 21909688
[TBL] [Abstract][Full Text] [Related]
29. Stathmin, a microtubule regulatory protein, is associated with hypoxia-inducible factor-1alpha levels in human endometrial and endothelial cells.
Yoshie M; Miyajima E; Kyo S; Tamura K
Endocrinology; 2009 May; 150(5):2413-8. PubMed ID: 19179443
[TBL] [Abstract][Full Text] [Related]
30. High Glucose Up-regulates ADAM17 through HIF-1α in Mesangial Cells.
Li R; Uttarwar L; Gao B; Charbonneau M; Shi Y; Chan JS; Dubois CM; Krepinsky JC
J Biol Chem; 2015 Aug; 290(35):21603-14. PubMed ID: 26175156
[TBL] [Abstract][Full Text] [Related]
31. Chlorogenic acid inhibits hypoxia-induced angiogenesis via down-regulation of the HIF-1α/AKT pathway.
Park JJ; Hwang SJ; Park JH; Lee HJ
Cell Oncol (Dordr); 2015 Apr; 38(2):111-8. PubMed ID: 25561311
[TBL] [Abstract][Full Text] [Related]
32. GDC-0941 inhibits metastatic characteristics of thyroid carcinomas by targeting both the phosphoinositide-3 kinase (PI3K) and hypoxia-inducible factor-1α (HIF-1α) pathways.
Burrows N; Babur M; Resch J; Ridsdale S; Mejin M; Rowling EJ; Brabant G; Williams KJ
J Clin Endocrinol Metab; 2011 Dec; 96(12):E1934-43. PubMed ID: 21994956
[TBL] [Abstract][Full Text] [Related]
33. A RNA antagonist of hypoxia-inducible factor-1alpha, EZN-2968, inhibits tumor cell growth.
Greenberger LM; Horak ID; Filpula D; Sapra P; Westergaard M; Frydenlund HF; Albaek C; Schrøder H; Ørum H
Mol Cancer Ther; 2008 Nov; 7(11):3598-608. PubMed ID: 18974394
[TBL] [Abstract][Full Text] [Related]
34. Topotecan blocks hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression induced by insulin-like growth factor-I in neuroblastoma cells.
Beppu K; Nakamura K; Linehan WM; Rapisarda A; Thiele CJ
Cancer Res; 2005 Jun; 65(11):4775-81. PubMed ID: 15930297
[TBL] [Abstract][Full Text] [Related]
35. A HIF-1alpha-dependent autocrine feedback loop promotes survival of serum-deprived prostate cancer cells.
Thomas R; Kim MH
Prostate; 2009 Feb; 69(3):263-75. PubMed ID: 19016246
[TBL] [Abstract][Full Text] [Related]
36. Cetuximab enhances the effect of oxaliplatin on hypoxic gastric cancer cell lines.
Luo HY; Wei W; Shi YX; Chen XQ; Li YH; Wang F; Qiu MZ; Li FH; Yan SL; Zeng MS; Huang P; Xu RH
Oncol Rep; 2010 Jun; 23(6):1735-45. PubMed ID: 20428833
[TBL] [Abstract][Full Text] [Related]
37. Resveratrol inhibits hypoxia-induced accumulation of hypoxia-inducible factor-1alpha and VEGF expression in human tongue squamous cell carcinoma and hepatoma cells.
Zhang Q; Tang X; Lu QY; Zhang ZF; Brown J; Le AD
Mol Cancer Ther; 2005 Oct; 4(10):1465-74. PubMed ID: 16227395
[TBL] [Abstract][Full Text] [Related]
38. 4-Hydroxy estradiol but not 2-hydroxy estradiol induces expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor A through phosphatidylinositol 3-kinase/Akt/FRAP pathway in OVCAR-3 and A2780-CP70 human ovarian carcinoma cells.
Gao N; Nester RA; Sarkar MA
Toxicol Appl Pharmacol; 2004 Apr; 196(1):124-35. PubMed ID: 15050414
[TBL] [Abstract][Full Text] [Related]
39. Anticancer imidazoacridinone C-1311 inhibits hypoxia-inducible factor-1α (HIF-1α), vascular endothelial growth factor (VEGF) and angiogenesis.
Paradziej-Łukowicz J; Skwarska A; Peszyńska-Sularz G; Brillowska-Dąbrowska A; Konopa J
Cancer Biol Ther; 2011 Oct; 12(7):586-97. PubMed ID: 21775820
[TBL] [Abstract][Full Text] [Related]
40. Down-regulating HIF-1α by lentivirus-mediated shRNA for therapy of triple negative breast cancer.
Li S; Wei Q; Li Q; Zhang B; Xiao Q
Cancer Biol Ther; 2015; 16(6):866-75. PubMed ID: 25920936
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
